AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Islamabad, Citi Pharma Ltd. (CPHL) announced moderate growth amidst market volatility at the Pakistan Stock Exchange (PSE). With a daily weighted average rate of Rs. 2,284.61, the pharmaceutical company continues to navigate through challenging market conditions. CPHL, listed since 2021, reported an EPS of Rs. 2.88 for the year 2022/2023, reflecting its steady performance in the sector. The company, with a paid-up capital of Rs. 27.26 million, did not declare any distributions for the year ending June. Despite market fluctuations, Citi Pharma remains resilient, with a book closure on October 20th and a market lot of 10 shares.
Check Also
Kot Addu Power Company Shareholder Reports Loss of 500 Shares
Karachi: Kot Addu Power Company Limited has reported the loss of a share certificate representing 500 shares owned by shareholder Saba Gul, as per a notice issued to the Pakistan Stock Exchange (PSX) on October 21, 2024. The lost certificate, detailed...
The post Kot Addu Power Company Shareholder Reports Loss of 500 Shares appeared first on .